Premature and accelerated aging: HIV or HAART?

108Citations
Citations of this article
205Readers
Mendeley users who have this article in their library.

Abstract

Highly active antiretroviral therapy (HAART) has significantly increased life expectancy of the human immunodeficiency virus (HlV)-positive population. Nevertheless, the average lifespan of HIV-patients remains shorter compared to uninfected individuals. Immunose-nescence, a current explanation for this difference invokes heavily on viral stimulus despite HAART efficiency in viral suppression. We propose here that the premature and accelerated aging of HIV-patients can also be caused by adverse effects of antiretroviral drugs, specifically those that affect the mitochondria. The nucleoside reverse transcriptase inhibitor (NRTI) antiretroviral drug class for instance, is known to cause depletion of mitochondrial DNA via inhibition of the mitochondrial specific DNA polymerase-y. Besides NRTIs, other antiretroviral drug classes such as protease inhibitors also cause severe mitochondrial damage by increasing oxidative stress and diminishing mitochondrial function. We also discuss important areas for future research and argue in favor of the use of Caenorhabditis elegans as a novel model system for studying these effects. © 2013 Smith, de Boer, Brul, Budovskaya and van der Spek.

Cite

CITATION STYLE

APA

Smith, R. L., de Boer, R., Brul, S., Budovskaya, Y., & van der Spek, H. (2013). Premature and accelerated aging: HIV or HAART? Frontiers in Genetics. https://doi.org/10.3389/fgene.2012.00328

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free